Atossa Therapeutics Announces Ovarian Cancer Patient has Begun Treatment with Oral Endoxifen under FDA’s Expanded Access Pathway

    NEXT STORY
    Cios Flow Mobile C-Arm Market Value Predicted To Reach US$ 4,676.5 Million By 2027 Covering Pre And Post COVID-19 Market Analysis: Acumen Research And Consulting
    PREV STORY
    Merit Medical to Present at 20th Annual Needham Healthcare Conference
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Akers Biosciences Reports Earnings for Fiscal Year 2017

    author_avatar
    NASDAQ Market News

    Notice to Convene an Extraordinary General Meeting

    author_avatar
    NASDAQ Market News

    Madrigal Pharmaceuticals Promotes Rebecca Taub, M.D., Chief Medical Officer and Executive Vice President of Research & Development, to Newly Created Position of President of Research & Development

    author_avatar
    NASDAQ Market News